Article: Cabot Medical begins clinical trials on advanced tubal occlusion system.

CABOT MEDICAL BEGINS CLINICAL TRIALS

ON ADVANCED TUBAL OCCLUSION SYSTEM

LANGHORNE, Pa., Nov. 16 /PRNewswire/ -- Cabot Medical Corporation (NASDAQ: CBOT) today announced it has begun clinical trials on an advanced tubal occlusion system.

"This new system will enhance Cabot's worldwide position in the permanent contraception market," said Warren Wood, president and CEO of Cabot. "Further, it allows us to penetrate a segment of the market where our existing system is not utilized."

Cabot's current line of KLI Falope-Ring(R) Bands has been proven through continual use to be a safe, effective, economical and virtually ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!